This is a Validated Antibody Database (VAD) review about human MYF5, based on 18 published articles (read how Labome selects the articles), using MYF5 antibody in all methods. It is aimed to help Labome visitors find the most suited MYF5 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
MYF5 synonym: EORVA; bHLHc2

Knockout validation
Santa Cruz Biotechnology
  • western blot; human; 1:1000; loading ...; fig s4b, 3e
  • western blot knockout validation; mouse; 1:1000; loading ...; fig s3a
Santa Cruz Biotechnology MYF5 antibody (Santa Cruz, C-20) was used in western blot on human samples at 1:1000 (fig s4b, 3e) and in western blot knockout validation on mouse samples at 1:1000 (fig s3a). Proc Natl Acad Sci U S A (2021) ncbi
Santa Cruz Biotechnology
  • western blot; human; 1:1000; loading ...; fig s4b, 3e
  • western blot knockout validation; mouse; 1:1000; loading ...; fig s3a
Santa Cruz Biotechnology MYF5 antibody (Santa Cruz, C-20) was used in western blot on human samples at 1:1000 (fig s4b, 3e) and in western blot knockout validation on mouse samples at 1:1000 (fig s3a). Proc Natl Acad Sci U S A (2021) ncbi
  • western blot; human; loading ...; fig 7b
Santa Cruz Biotechnology MYF5 antibody (Santa Cruz, C20) was used in western blot on human samples (fig 7b). Biochemistry (2018) ncbi
  • western blot; mouse; 1:200; loading ...; fig 7h
In order to examine the role of laminin on type I and type II pericyte proliferation and differentiation, Santa Cruz Biotechnology MYF5 antibody (Santa Cruz, sc-302) was used in western blot on mouse samples at 1:200 (fig 7h). Stem Cell Res Ther (2017) ncbi
  • western blot; pigs ; loading ...; fig 3c
Santa Cruz Biotechnology MYF5 antibody (Santa Cruz, sc-302) was used in western blot on pigs samples (fig 3c). Sci Rep (2017) ncbi
  • western blot; human; 1:1000; loading ...; fig 2
In order to elucidate the mechanisms by which Annexin A1 governs metastatic behavior in prostate cancer cells exposed to hypoxia, Santa Cruz Biotechnology MYF5 antibody (Santa Cruz Biotechnologies, C-20) was used in western blot on human samples at 1:1000 (fig 2). Cell Adh Migr (2017) ncbi
  • immunohistochemistry - frozen section; mouse; loading ...; fig 6b
In order to use knockout mice to determine the role of a2V in mammary gland development, Santa Cruz Biotechnology MYF5 antibody (Santa Cruz, C-20) was used in immunohistochemistry - frozen section on mouse samples (fig 6b). Cell Death Dis (2016) ncbi
  • western blot; mouse; loading ...; fig 2d
In order to explore the expression and function of 4.1R during myogenesis, Santa Cruz Biotechnology MYF5 antibody (Santa Cruz, C-20) was used in western blot on mouse samples (fig 2d). J Biol Chem (2016) ncbi
  • immunocytochemistry; mouse; 1:2000; loading ...; fig 2h
  • western blot; human; 1:2000; fig 7d
In order to explore the anti-viral effects of iRhom2, Santa Cruz Biotechnology MYF5 antibody (Santa Cruz, C-20) was used in immunocytochemistry on mouse samples at 1:2000 (fig 2h) and in western blot on human samples at 1:2000 (fig 7d). Nat Immunol (2016) ncbi
  • immunoprecipitation; mouse; loading ...; fig 7d
  • western blot; mouse; loading ...; fig 7d
In order to study the contribution of cdk4 to non-alcoholic fatty liver disease, Santa Cruz Biotechnology MYF5 antibody (Santa Cruz, C-20) was used in immunoprecipitation on mouse samples (fig 7d) and in western blot on mouse samples (fig 7d). Cell Rep (2016) ncbi
  • immunocytochemistry; mouse; 1:100; fig 3
Santa Cruz Biotechnology MYF5 antibody (santa Cruz, sc302) was used in immunocytochemistry on mouse samples at 1:100 (fig 3). J Clin Invest (2016) ncbi
  • other; human; loading ...; fig st1
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, Santa Cruz Biotechnology MYF5 antibody (SCBT, C-20) was used in other on human samples (fig st1). Mol Cell Proteomics (2016) ncbi
  • immunoprecipitation; human; loading ...; fig 6e
  • western blot; human; loading ...; fig 6b
Santa Cruz Biotechnology MYF5 antibody (Santa Cruz, C-20) was used in immunoprecipitation on human samples (fig 6e) and in western blot on human samples (fig 6b). Nucleic Acids Res (2015) ncbi
  • western blot; mouse; loading ...; fig 2b
In order to identify p300/beta-catenin antagonists and verify their ability to maintain pluripotency in ESC, Santa Cruz Biotechnology MYF5 antibody (Santa Cruz, sc-302) was used in western blot on mouse samples (fig 2b). Curr Mol Pharmacol (2016) ncbi
  • western blot; human; loading ...; fig 2b
Santa Cruz Biotechnology MYF5 antibody (Santa Cruz, C-20) was used in western blot on human samples (fig 2b). PLoS Pathog (2015) ncbi
  • flow cytometry; mouse; fig 4
Santa Cruz Biotechnology MYF5 antibody (Santa Cruz, 30.2) was used in flow cytometry on mouse samples (fig 4). Science (2015) ncbi
  • western blot; human; loading ...; fig 3a
In order to investigate the effects of lymphopenia and chronic exposure to IFN on T cell homeostasis, Santa Cruz Biotechnology MYF5 antibody (Santa Cruz, C-20) was used in western blot on human samples (fig 3a). PLoS Pathog (2014) ncbi
Abcam
domestic rabbit monoclonal (EPR4899)
  • immunohistochemistry - paraffin section; human; loading ...; fig 3k
Abcam MYF5 antibody (Abcam, ab125078) was used in immunohistochemistry - paraffin section on human samples (fig 3k). Cancer Cell (2018) ncbi
domestic rabbit monoclonal (EPR4899)
  • western blot; human; loading ...; fig 5c
Abcam MYF5 antibody (Abcam, ab125078) was used in western blot on human samples (fig 5c). Free Radic Biol Med (2017) ncbi
Articles Reviewed
  1. Goyette M, Elkholi I, Apcher C, Kuasne H, Rothlin C, Muller W, et al. Targeting Axl favors an antitumorigenic microenvironment that enhances immunotherapy responses by decreasing Hif-1α levels. Proc Natl Acad Sci U S A. 2021;118: pubmed publisher
  2. Stewart E, McEvoy J, Wang H, Chen X, Honnell V, Ocarz M, et al. Identification of Therapeutic Targets in Rhabdomyosarcoma through Integrated Genomic, Epigenomic, and Proteomic Analyses. Cancer Cell. 2018;34:411-426.e19 pubmed publisher
  3. Wang Z, Kim M, Martinez Ferrando I, Koleske A, Pandey A, Cole P. Analysis of Cellular Tyrosine Phosphorylation via Chemical Rescue of Conditionally Active Abl Kinase. Biochemistry. 2018;57:1390-1398 pubmed publisher
  4. Potes Y, de Luxán Delgado B, Rodríguez González S, Guimarães M, Solano J, Fernández Fernández M, et al. Overweight in elderly people induces impaired autophagy in skeletal muscle. Free Radic Biol Med. 2017;110:31-41 pubmed publisher
  5. Gautam J, Nirwane A, Yao Y. Laminin differentially regulates the stemness of type I and type II pericytes. Stem Cell Res Ther. 2017;8:28 pubmed publisher
  6. Genovese N, Domeier T, Telugu B, Roberts R. Enhanced Development of Skeletal Myotubes from Porcine Induced Pluripotent Stem Cells. Sci Rep. 2017;7:41833 pubmed publisher
  7. Bizzarro V, Belvedere R, Migliaro V, Romano E, Parente L, Petrella A. Hypoxia regulates ANXA1 expression to support prostate cancer cell invasion and aggressiveness. Cell Adh Migr. 2017;11:247-260 pubmed publisher
  8. Pamarthy S, Mao L, Katara G, Fleetwood S, Kulshreshta A, Gilman Sachs A, et al. The V-ATPase a2 isoform controls mammary gland development through Notch and TGF-β signaling. Cell Death Dis. 2016;7:e2443 pubmed publisher
  9. Huang S, Zhou A, Nguyen D, Zhang H, Benz E. Protein 4.1R Influences Myogenin Protein Stability and Skeletal Muscle Differentiation. J Biol Chem. 2016;291:25591-25607 pubmed
  10. Luo W, Li S, Li C, Lian H, Yang Q, Zhong B, et al. iRhom2 is essential for innate immunity to DNA viruses by mediating trafficking and stability of the adaptor STING. Nat Immunol. 2016;17:1057-66 pubmed publisher
  11. Jin J, Valanejad L, Nguyen T, Lewis K, Wright M, Cast A, et al. Activation of CDK4 Triggers Development of Non-alcoholic Fatty Liver Disease. Cell Rep. 2016;16:744-56 pubmed publisher
  12. Faralli H, Wang C, Nakka K, Benyoucef A, Sebastian S, Zhuang L, et al. UTX demethylase activity is required for satellite cell-mediated muscle regeneration. J Clin Invest. 2016;126:1555-65 pubmed publisher
  13. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed publisher
  14. Keka I, Mohiuddin -, Maede Y, Rahman M, Sakuma T, Honma M, et al. Smarcal1 promotes double-strand-break repair by nonhomologous end-joining. Nucleic Acids Res. 2015;43:6359-72 pubmed publisher
  15. Higuchi Y, Nguyen C, Yasuda S, McMillan M, Hasegawa K, Kahn M. Specific Direct Small Molecule p300/?-Catenin Antagonists Maintain Stem Cell Potency. Curr Mol Pharmacol. 2016;9:272-279 pubmed
  16. Kim Y, Ahn J. Positive role of promyelocytic leukemia protein in type I interferon response and its regulation by human cytomegalovirus. PLoS Pathog. 2015;11:e1004785 pubmed publisher
  17. Yang S, Fujikado N, Kolodin D, Benoist C, Mathis D. Immune tolerance. Regulatory T cells generated early in life play a distinct role in maintaining self-tolerance. Science. 2015;348:589-94 pubmed publisher
  18. Le Saout C, Hasley R, Imamichi H, Tcheung L, Hu Z, Luckey M, et al. Chronic exposure to type-I IFN under lymphopenic conditions alters CD4 T cell homeostasis. PLoS Pathog. 2014;10:e1003976 pubmed publisher